Er. Butelman et al., Apparent efficacy of kappa-opioid receptor ligands on serum prolactin levels in rhesus monkeys, EUR J PHARM, 383(3), 1999, pp. 305-309
These studies investigated whether serum prolactin levels could be a quanti
tative marker of the apparent efficacy of K-opioid receptor ligands in prim
ates. The effects of s.c. bremazocine and U50,488 (trans-(+/-)-3,4-Dichloro
-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]-benzeneacetamide; agonists), na
lorphine (partial agonist) and nalmefene (antagonist) on prolactin levels w
ere studied in intact female rhesus monkeys. The above compounds, except na
lmefene, increased prolactin levels, and their actions conformed to sigmoid
al dose-effect curves. The rank order of the compounds' maximum effects in
this neuroendocrine endpoint is similar to that in cloned K-receptors in vi
tro, and in a presently studied thermal antinociception assay in vivo. Prol
actin may therefore be a quantitative marker of the apparent efficacy of K-
opioid receptor ligands in primates. (C) 1999 Elsevier Science B.V. All rig
hts reserved.